Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared on reposted from The Lancet Hematology on LinkedIn:
”Check out this podcast from The Lancet Haematology to help you plan your ASH25, we give an overview of key novelties to look out for across various sessions!”
Qutoing The Lancet Hematology‘s post:
”Are you planning to attend ASH25 in Orlando?
There’s no better way to get a sneak peek at the exciting content than hearing experts share their insights firsthand.
In our latest special episode of In Conversation With, a roundtable of leading classical and malignant haematology thought leaders — Khaled Musallam, Bethany Samuelson Bannow, Mohamad Mohty, David Sallman, and Anna Sureda Balari — preview the most anticipated ASH25 sessions and their expectations for the upcoming congress.
They discuss practical implications for clinicians, researchers, and trainees, and offer takeaways to maximise your time at the meeting.
Key areas covered:
- Thalassaemia and sickle cell disease
- Thrombosis and bleeding disorders
- Multiple myeloma
- Myeloid neoplasms
- Cellular therapies, stem-cell transplantation, and lymphoma
Tune in now; search The Lancet Haematology wherever you get your podcasts.
If you’re attending ASH25 or following from afar, please share with colleagues preparing for the meeting!
Don’t forget to hit subscribe to stay ahead with the latest in haematology!”

Find the full coverage of ASH25 in Hemostasis Today.
-
Mar 5, 2026, 17:48Estelle Carminita։ What If the Origin of Platelet Dysfunction Starts in the Bone Marrow
-
Mar 5, 2026, 17:43Pierre Sabouret: The Best Antithrombotic Strategy in Patients with Atherosclerotic Stroke and AF
-
Mar 5, 2026, 17:37John Abraham։ The Role of Diagnostic Splenectomy in Unexplained Splenomegaly
-
Mar 5, 2026, 17:31Fayad Al-Haimus: Key Themes from the New 2026 AHA/ACC Guideline for Acute PE
-
Mar 5, 2026, 16:56From Chronic Pain with Every Step to Exercising Every Day – EHC
-
Mar 5, 2026, 15:51Samer Al Hadidi: Cytopenias and Infection Risk With BCMA-Directed Bispecific Antibodies
-
Mar 5, 2026, 15:35Ney Carter Borges: Cholesterol-Inflammation Fusion in Atherosclerosis
-
Mar 5, 2026, 15:33Nicolas Hubacz: How Stress Shapes Organ Development
-
Mar 5, 2026, 15:28Charles Greenberg: What If D-dimer Isn’t ‘Non-Specific’ At All?